[1]
|
乔杰, 宋艳红. 谷氨酰转肽酶的研究进展[J]. 医学理论与实践, 2019, 32(5): 651-653.
|
[2]
|
Lim, J.S., Yang, J.H., Chun, B.Y., et al. (2004) Is Serum Gamma-Glutamyltransferase Inversely Associated with Serum Antioxidants as a Marker of Oxidative Stress? Free Radical Biology and Medicine, 37, 1018-1023.
https://doi.org/10.1016/j.freeradbiomed.2004.06.032
|
[3]
|
Pastore, A., Federici, G., Bertini, E., et al. (2003) Analysis of Glutathione: Implication in Redox and Detoxification. Clinica Chimica Acta, 333, 19-39. https://doi.org/10.1016/S0009-8981(03)00200-6
|
[4]
|
Corti, A., Franzini, M., Paolicchi, A., et al. (2010) Gamma-Glutamyltransferase of Cancer Cells at the Crossroads of Tumor Progression, Drug Resistance and Drug Targeting. Anticancer Research, 30, 1169-1181.
|
[5]
|
Whitfield, J.B. (2001) Gamma Glutamyl Transferase. Critical Reviews in Clinical Laboratory Sciences, 38, 263-355.
https://doi.org/10.1080/20014091084227
|
[6]
|
Pompella, A., De Tata, V., Paolicchi, A., et al. (2006) Expression of Gamma-Glutamyltransferase in Cancer Cells and Its Significance in Drug Resistance. Biochemical Pharmacology, 71, 231-238.
https://doi.org/10.1016/j.bcp.2005.10.005
|
[7]
|
Pompella, A., Corti, A., Paolicchi, A., et al. (2007) Gamma-Glutamyltransferase, Redox Regulation and Cancer Drug Resistance. Current Opinion in Pharmacology, 7, 360-366. https://doi.org/10.1016/j.coph.2007.04.004
|
[8]
|
Dilda, P.J., Ramsay, E.E., Corti, A., et al. (2008) Metabolism of the Tumor Angiogenesis Inhibitor 4-(N-(S-Glutathi- onylacetyl)Amino) Phenylarsonous Acid. Journal of Biological Chemistry, 283, 35428-35434.
https://doi.org/10.1074/jbc.M804470200
|
[9]
|
Roomi, M.W., Gaal, K., Yuan, Q.X., et al. (2006) Preneoplastic Liver Cell Foci Expansion Induced by Thioacetamide Toxicity in Drug-Primed Mice. Experimental and Molecular Pathology, 81, 8-14.
https://doi.org/10.1016/j.yexmp.2006.02.006
|
[10]
|
Borud, O., Mortensen, B., Mikkelsen, I.M., et al. (2000) Regulation of Gamma-Glutamyltransferase in Cisplatin-Re- sistant and -Sensitive Colon Carcinoma Cells after Acute Cisplatin and Oxidative Stress Exposures. International Journal of Cancer, 88, 464-468. https://doi.org/10.1002/1097-0215(20001101)88:3<464::AID-IJC20>3.0.CO;2-F
|
[11]
|
Mikkelsen, I.M., Huseby, N.E., Visvikis, A., et al. (2002) Activation of the Gamma-Glutamyltransferase Promoter 2 in the Rat Colon Carcinoma Cell Line CC531 by Histone Deacetylase Inhibitors Is Mediated Through the Sp1 Binding Motif. Biochemical Pharmacology, 64, 307-315. https://doi.org/10.1016/S0006-2952(02)01116-4
|
[12]
|
Daubeuf, S., Duvoix, A., Wellman-Rousseau, M., et al. (2004) Phorbol Ester Regulation of the Human Gamma-Glu- tamyltransferase Gene Promoter. Biochemical and Biophysical Research Communications, 313, 300-307.
https://doi.org/10.1016/j.bbrc.2003.11.121
|
[13]
|
Zhang, H., Liu, H., Iles, K.E., et al. (2006) 4-Hydroxynonenal Induces Rat Gamma-Glutamyl Transpeptidase Through Mitogen-Activated Protein Kinase-Mediated Electrophile Response Element/nuclear Factor Erythroid 2-Related Factor 2 Signaling. The American Journal of Respiratory Cell and Molecular Biology, 34, 174-181.
https://doi.org/10.1165/rcmb.2005-0280OC
|
[14]
|
Pandur, S., Pankiv, S., Johannessen, M., et al. (2007) Gamma-Glutamyltransferase Is Upregulated after Oxidative Stress through the Ras Signal Transduction Pathway in Rat Colon Carcinoma Cells. Free Radical Research, 41, 1376-1384.
https://doi.org/10.1080/10715760701739488
|
[15]
|
Daubeuf, S., Accaoui, M.J., Pettersen, I., et al. (2001) Differential Regulation of Gamma-Glutamyltransferase MRNAs in Four Human Tumour Cell Lines. Biochimica et Biophysica Acta, 1568, 67-73.
https://doi.org/10.1016/S0304-4165(01)00201-X
|
[16]
|
Bouman, L., Sancéau, J., Rouillard, D., et al. (2002) Gamma-Glutamyl Transpeptidase Expression in Ewing’s Sarcoma Cells: Up-Regulation by Interferons. Biochemical Journal, 364, 719-724. https://doi.org/10.1042/bj20011854
|
[17]
|
Reuter, S., Schnekenburger, M., Cristofanon, S., et al. (2009) Tumor Necrosis Factor Alpha Induces Gamma-Gluta- myltransferase Expression Via Nuclear Factor-KappaB in Cooperation with Sp1. Biochemical Pharmacology, 77, 397- 411. https://doi.org/10.1016/j.bcp.2008.09.041
|
[18]
|
Murata, J., Ricciardi-Castagnoli, P., Dessous L’Eglise Mange, P., et al. (1997) Microglial Cells Induce Cytotoxic Effects toward Colon Carcinoma Cells: Measurement of Tumor Cytotoxicity with a Gamma-Glutamyl Transpeptidase Assay. International Journal of Cancer, 70, 169-174.
https://doi.org/10.1002/(SICI)1097-0215(19970117)70:2<169::AID-IJC6>3.0.CO;2-V
|
[19]
|
Tsutsumi, M., Sakamuro, D., Takada, A., et al. (1996) Detection of a Unique Gamma-Glutamyl Transpeptidase Messenger RNA Species Closely Related to the Development of Hepatocellular Carcinoma in Humans: A New Candidate for Early Diagnosis of Hepatocellular Carcinoma. Hepatology, 23, 1093-1097.
https://doi.org/10.1053/jhep.1996.v23.pm0008621139
|
[20]
|
Schäfer, C., Fels, C., Brucke, M., et al. (2001) Gamma-Glutamyl Transferase Expression in Higher-Grade Astrocytic Glioma. Acta Oncologica, 40, 529-535.
|
[21]
|
Paolicchi, A., Pompella, A., Tonarelli, P., et al. (1996) Gamma-Glutamyltranspeptidase Activity in Human Ovarian Carcinoma. Anticancer Research, 16, 3053-3058.
|
[22]
|
Hanigan, M.H., Frierson, Jr., H.F., Swanson, P.E. and De Young, B.R. (1999) Altered Expression of Gamma-Glutamyl Transpeptidase in Human Tumors. Human Pathology, 30, 300-305. https://doi.org/10.1016/S0046-8177(99)90009-6
|
[23]
|
Prezioso, J.A., Wang, N., Duty, L., et al. (1993) Enhancement of Pulmonary Metastasis Formation and Gamma-Glu- tamyltranspeptidase Activity in B16 Melanoma Induced by Differentiation in Vitro. Clinical & Experimental Metastasis, 11, 263-274. https://doi.org/10.1007/BF00121169
|
[24]
|
Staudigl, C., Concin, N., Grimm, C., et al. (2015) Prognostic Relevance of Pretherapeutic Gamma-Glutamyltransferase in Patients with Primary Metastatic Breast Cancer. PLoS ONE, 10, Article ID: e0125317.
https://doi.org/10.1371/journal.pone.0125317
|
[25]
|
张义静, 马莎, 魏晋, 曹希亮, 陈伟, 祁岳坤. 肾癌患者术前血清γ-谷氨酰转肽酶水平与术后生存的相关性研究[J]. 肿瘤研究与临床, 2021, 33(9): 668-672.
|
[26]
|
Takemura, K., Board, P.G. and Koga, F. (2021) A Systematic Review of Serum γ-Glutamyltransferase as a Prognostic Biomarker in Patients with Genitourinary Cancer. Antioxidants, 10, Article No. 549.
https://doi.org/10.3390/antiox10040549
|
[27]
|
Ozdemirler, G., Pabuççuoglu, H., Bulut, T., et al. (1998) Increased Lipoperoxide Levels and Antioxidant System in Colorectal Cancer. Journal of Cancer Research and Clinical Oncology, 124, 555-559.
https://doi.org/10.1007/s004320050214
|
[28]
|
Koenig, G. and Seneff, S. (2015) Gamma-Glutamyltransferase: A Predictive Biomarker of Cellular Antioxidant Inadequacy and Disease Risk. Disease Markers, 2015, Article ID: 818570. https://doi.org/10.1155/2015/818570
|
[29]
|
Kunutsor, S.K., Apekey, T.A. and Seddoh, D. (2015) Gamma Glutamyltransferase and Metabolic Syndrome Risk: A Systematic Review and Dose-Response Meta-Analysis. International Journal of Clinical Practice, 69, 136-144.
https://doi.org/10.1111/ijcp.12507
|
[30]
|
Hanigan, M.H. (1995) Expression of Gamma-Glutamyl Transpeptidase Provides Tumor Cells with a Selective Growth Advantage at Physiologic Concentrations of Cyst(e)ine. Carcinogenesis, 16, 181-185.
https://doi.org/10.1093/carcin/16.2.181
|
[31]
|
Hochwald, S.N., Harrison, L.E., Rose, D.M., et al. (1996) Gamma-Glutamyl Transpeptidase Mediation of Tumor Glutathione Utilization in Vivo. Journal of the National Cancer Institute, 88, 193-197.
https://doi.org/10.1093/jnci/88.3-4.193
|
[32]
|
Franzini, M., Corti, A., Lorenzini, E., et al. (2006) Modulation of Cell Growth and Cisplatin Sensitivity by Membrane Gamma-Glutamyltransferase in Melanoma Cells. European Journal of Cancer, 42, 2623-2630.
https://doi.org/10.1016/j.ejca.2006.04.016
|
[33]
|
Ruoso, P. and Hedley, D.W. (2004) Inhibition of Gamma-Glutamyl Transpeptidase Activity Decreases Intracellular Cysteine Levels in Cervical Carcinoma. Cancer Chemotherapy and Pharmacology, 54, 49-56.
https://doi.org/10.1007/s00280-004-0776-3
|
[34]
|
Corti, A., Belcastro, E., Dominici, S., et al. (2020) The Dark Side of Gamma-Glutamyltransferase (GGT): Pathogenic Effects of An ‘antioxidant’ Enzyme. Free Radical Biology & Medicine, 160, 807-819.
https://doi.org/10.1016/j.freeradbiomed.2020.09.005
|
[35]
|
Spear, N. and Aust, S.D. (1994) Thiol-Mediated NTA-Fe(III) Reduction and Lipid Peroxidation. Archives of Biochemistry and Biophysics, 312, 198-202. https://doi.org/10.1006/abbi.1994.1299
|
[36]
|
Stark, A.A., Russell, J.J., Langenbach, R., et al. (1994) Localization of Oxidative Damage by a Glutathione-Gamma- Glutamyl Transpeptidase System in Preneoplastic Lesions in Sections of Livers from Carcinogen-Treated Rats. Carcinogenesis, 15, 343-348. https://doi.org/10.1093/carcin/15.2.343
|
[37]
|
Stark, A.A. and Glass, G.A. (1997) Role of Copper and Ceruloplasmin in Oxidative Mutagenesis Induced by the Glutathione-Gamma-Glutamyl Transpeptidase System and by Other Thiols. Environmental and Molecular Mutagenesis, 29, 63-72. https://doi.org/10.1002/(SICI)1098-2280(1997)29:1<63::AID-EM9>3.0.CO;2-E
|
[38]
|
Corti, A., Duarte, T.L., Giommarelli, C., et al. (2009) Membrane Gamma-Glutamyl Transferase Activity Promotes Iron-Dependent Oxidative DNA Damage in Melanoma Cells. Mutation Research, 669, 112-121.
https://doi.org/10.1016/j.mrfmmm.2009.05.010
|
[39]
|
Drozdz, R., Parmentier, C., Hachad, H., et al. (1998) Gamma-Glutamyltransferase Dependent Generation of Reactive Oxygen Species from a Glutathione/Transferrin System. Free Radical Biology & Medicine, 25, 786-792.
https://doi.org/10.1016/S0891-5849(98)00127-0
|
[40]
|
Toyokuni, S., Okamoto, K., Yodoi, J., et al. (1995) Persistent Oxidative Stress in Cancer. FEBS Letters, 358, 1-3.
https://doi.org/10.1016/0014-5793(94)01368-B
|
[41]
|
Sen, C.K. (1998) Redox Signaling and the Emerging Therapeutic Potential of Thiol Antioxidants. Biochemical Pharmacology, 55, 1747-1758. https://doi.org/10.1016/S0006-2952(97)00672-2
|
[42]
|
Maellaro, E., Dominici, S., Del Bello, B., et al. (2000) Membrane Gamma-Glutamyl Transpeptidase Activity of Melanoma Cells: Effects on Cellular H2O2 Production, Cell Surface Protein Thiol Oxidation and NF-Kappa B Activation Status. Journal of Cell Science, 113, 2671-2678. https://doi.org/10.1242/jcs.113.15.2671
|
[43]
|
Dominici, S., Visvikis, A., Pieri, L., et al. (2003) Redox Modulation of NF-KappaB Nuclear Translocation and DNA Binding in Metastatic Melanoma. The Role of Endogenous and Gamma-Glutamyl Transferase-Dependent Oxidative Stress. Tumori Journal, 89, 426-433. https://doi.org/10.1177/030089160308900416
|
[44]
|
Foyer, C.H., Wilson, M.H. and Wright, M.H. (2018) Redox Regulation of Cell Proliferation: Bioinformatics and Redox Proteomics Approaches to Identify Redox-Sensitive Cell Cycle Regulators. Free Radical Biology & Medicine, 122, 137-149. https://doi.org/10.1016/j.freeradbiomed.2018.03.047
|
[45]
|
Perego, P., Paolicchi, A., Tongiani, R., et al. (1997) The Cell-Specific Anti-Proliferative Effect of Reduced Glutathione Is Mediated by Gamma-Glutamyl Transpeptidase-Dependent Extracellular Pro-Oxidant Reactions. International Journal of Cancer, 71, 246-250.
https://doi.org/10.1002/(SICI)1097-0215(19970410)71:2<246::AID-IJC20>3.0.CO;2-E
|
[46]
|
del Bello, B., Paolicchi, A., Comporti, M., et al. (1999) Hydrogen Peroxide Produced During Gamma-Glutamyl Transpeptidase Activity Is Involved in Prevention of Apoptosis and Maintainance of Proliferation in U937 Cells. The FASEB Journal, 13, 69-79. https://doi.org/10.1096/fasebj.13.1.69
|
[47]
|
Giommarelli, C., Corti, A., Supino, R., et al. (2008) Cellular Response to Oxidative Stress and Ascorbic Acid in Melanoma Cells Overexpressing Gamma-Glutamyltransferase. European Journal of Cancer, 44, 750-759.
https://doi.org/10.1016/j.ejca.2008.02.010
|
[48]
|
Corti, A., Raggi, C., Franzini, M., et al. (2004) Plasma Membrane Gamma-Glutamyltransferase Activity Facilitates the Uptake of Vitamin C in Melanoma Cells. Free Radical Biology & Medicine, 37, 1906-1915.
https://doi.org/10.1016/j.freeradbiomed.2004.08.015
|
[49]
|
Shi, M., Gozal, E., Choy, H.A., et al. (1993) Extracellular Glutathione and Gamma-Glutamyl Transpeptidase Prevent H2O2-Induced Injury by 2,3-Dimethoxy-1,4-Naphthoquinone. Free Radical Biology & Medicine, 15, 57-67.
https://doi.org/10.1016/0891-5849(93)90125-E
|
[50]
|
Hochwald, S.N., Rose, D.M., Brennan, M.F., et al. (1997) Elevation of Glutathione and Related Enzyme Activities in High-Grade and Metastatic Extremity Soft Tissue Sarcoma. Annals of Surgical Oncology, 4, 303-309.
https://doi.org/10.1007/BF02303579
|
[51]
|
Mares, V., Lisá, V., Malík, R., et al. (2003) Cisplatin Induced Gamma-Glutamyltransferase Up-Regulation, Hypertrophy and Differentiation in Astrocytic Glioma Cells in Culture. Histology and Histopathology, 18, 687-693.
|
[52]
|
Benlloch, M., Ortega, A., Ferrer, P., et al. (2005) Acceleration of Glutathione Efflux and Inhibition of Gamma-Glu- tamyltranspeptidase Sensitize Metastatic B16 Melanoma Cells to Endothelium-Induced Cytotoxicity. Journal of Biological Chemistry, 280, 6950-6959. https://doi.org/10.1074/jbc.M408531200
|
[53]
|
Warren, B.S., Naylor, M.F., Winberg, L.D., et al. (1993) Induction and Inhibition of Tumor Progression. Proceedings of the Society for Experimental Biology and Medicine, 202, 19-15. https://doi.org/10.3181/00379727-202-43511B
|
[54]
|
Paolicchi, A., Lorenzini, E., Perego, P., et al. (2002) Extra-Cellular Thiol Metabolism in Clones of Human Metastatic Melanoma with Different Gamma-Glutamyl Transpeptidase Expression: Implications for Cell Response to Platinum-Based Drugs. International Journal of Cancer, 97, 740-745. https://doi.org/10.1002/ijc.10110
|
[55]
|
Perego, P., Romanelli, S., Carenini, N., et al. (1998) Ovarian Cancer Cisplatin-Resistant Cell Lines: Multiple Changes Including Collateral Sensitivity to Taxol. Annals of Oncology, 9, 423-430. https://doi.org/10.1023/A:1008265012435
|
[56]
|
Hanigan, M.H., Frierson Jr., H.F., Abeler, V.M., et al. (1999) Human Germ Cell Tumours: Expression of Gamma- Glutamyl Transpeptidase and Sensitivity to Cisplatin. British Journal of Cancer, 81, 75-79.
https://doi.org/10.1038/sj.bjc.6690653
|
[57]
|
Zimmermann, T., Zeizinger, M. and Burda, J.V. (2005) Cisplatin Interaction with Cysteine and Methionine, a Theoretical DFT Study. Journal of Inorganic Biochemistry, 99, 2184-2196. https://doi.org/10.1016/j.jinorgbio.2005.07.021
|
[58]
|
Paolicchi, A., Sotiropuolou, M., Perego, P., et al. (2003) Gamma-Glutamyl Transpeptidase Catalyses the Extracellular Detoxification of Cisplatin in a Human Cell Line Derived from the Proximal Convoluted Tubule of the Kidney. European Journal of Cancer, 39, 996-1003. https://doi.org/10.1016/S0959-8049(03)00067-4
|
[59]
|
Jerremalm, E., Wallin, I., Yachnin, J., et al. (2006) Oxaliplatin Degradation in the Presence of Important Biological Sulphur-Containing Compounds and Plasma Ultrafiltrate. European Journal of Pharmaceutical Sciences, 28, 278-283.
https://doi.org/10.1016/j.ejps.2006.03.001
|
[60]
|
Daubeuf, S., Leroy, P., Paolicchi, A., et al. (2002) Enhanced Resistance of HeLa Cells to Cisplatin by Overexpression of Gamma-Glutamyltransferase. Biochemical Pharmacology, 64, 207-216.
https://doi.org/10.1016/S0006-2952(02)01118-8
|
[61]
|
Arany, I., Safirstein, R.L. (2003) Cisplatin Nephrotoxicity. Seminars in Nephrology, 23, 460-464.
https://doi.org/10.1016/S0270-9295(03)00089-5
|
[62]
|
Zhang, L. and Hanigan, M.H. (2003) Role of Cysteine S-Conjugate Beta-Lyase in the Metabolism of Cisplatin. Journal of Pharmacology and Experimental Therapeutics, 306, 988-994. https://doi.org/10.1124/jpet.103.052225
|
[63]
|
Hanigan, M.H., Lykissa, E.D., Townsend, D.M., et al. (2001) Gamma-Glutamyl Transpeptidase-Deficient Mice Are Resistant to the Nephrotoxic Effects of Cisplatin. The American Journal of Pathology, 159, 1889-1894.
https://doi.org/10.1016/S0002-9440(10)63035-0
|
[64]
|
Hanigan, M.H., Gallagher, B.C., Taylor Jr., P.T., et al. (1994) Inhibition of Gamma-Glutamyl Transpeptidase Activity by Acivicin in Vivo Protects the Kidney from Cisplatin-Induced Toxicity. Cancer Research, 54, 5925-5929.
|
[65]
|
Townsend, D.M. and Hanigan, M.H. (2002) Inhibition of Gamma-Glutamyl Transpeptidase Or Cysteine S-Conjugate Beta-Lyase Activity Blocks the Nephrotoxicity of Cisplatin in Mice. Journal of Pharmacology and Experimental Therapeutics, 300, 142-148. https://doi.org/10.1124/jpet.300.1.142
|
[66]
|
Wainford, R.D., Weaver, R.J., Stewart, K.N., et al. (2008) Cisplatin Nephrotoxicity Is Mediated by Gamma Glutamyltranspeptidase, Not Via a C-S Lyase Governed Biotransformation Pathway. Toxicology, 249, 184-193.
https://doi.org/10.1016/j.tox.2008.05.006
|
[67]
|
Zunino, F., Pratesi, G., Micheloni, A., et al. (1989) Protective Effect of Reduced Glutathione against Cisplatin-Induced Renal and Systemic Toxicity and Its Influence on the Therapeutic Activity of the Antitumor Drug. Chemico-Biological Interaction, 70, 89-101. https://doi.org/10.1016/0009-2797(89)90065-3
|
[68]
|
Bernareggi, A., Torti, L., Facino, R.M., et al. (1995) Characterization of Cisplatin-Glutathione Adducts by Liquid Chromatography-Mass Spectrometry. Evidence for Their Formation in Vitro but Not in Vivo after Concomitant Administration of Cisplatin and Glutathione to Rats ANC Cancer Patients. Journal of Chromatography B: Biomedical Sciences and Applications, 669, 247-263. https://doi.org/10.1016/0378-4347(95)00098-4
|
[69]
|
Griffith, O.W. and Meister, A. (1979) Translocation of Intracellular Glutathione to Membrane-Bound Gamma-Glutamyl Transpeptidase as a Discrete Step in the Gamma-Glutamyl Cycle: Glutathionuria after Inhibition of Transpeptidase. Proceedings of the National Academy of Sciences of the United States of America, 76, 268-272.
https://doi.org/10.1073/pnas.76.1.268
|
[70]
|
Lieberman, M.W., Wiseman, A.L., Shi, Z.Z., et al. (1996) Growth Retardation and Cysteine Deficiency in Gamma- Glutamyl Transpeptidase-Deficient Mice. Proceedings of the National Academy of Sciences of the United States of America, 93, 7923-7926. https://doi.org/10.1073/pnas.93.15.7923
|
[71]
|
Larsson, A., Orrenius, S., Holmgren, A., Mannervik, B. and Meister, A. (1983) Metabolism and Transport of Glutathione and Other Gamma-Glutamyl Compounds. In: Larsson, A., Orrenius, S., Holmgren, A. and Mannervik, B., Eds, Functions of Glutathione: Biochemical, Toxicological and Clinical Aspects, Raven Press, New York, 1-22.
|
[72]
|
Heudi, O., Brisset, H., Cailleux, A., et al. (2001) Chemical Instability and Methods for Measurement of Cisplatin Adducts Formed by Interactions with Cysteine and Glutathione. International Journal of Clinical Pharmacology and Therapeutics, 39, 344-349. https://doi.org/10.5414/CPP39344
|
[73]
|
Mena, S., Benlloch, M., Ortega, A., et al. (2007) Bcl-2 and Glutathione Depletion Sensitizes B16 Melanoma to Combination Therapy and Eliminates Metastatic Disease. Clinical Cancer Research, 13, 2658-2666.
https://doi.org/10.1158/1078-0432.CCR-06-2642
|
[74]
|
Lherbet, C., Gravel, C. and Keillor, J.W. (2004) Synthesis of S-Alkyl L-Homocysteine Analogues of Glutathione and Their Kinetic Studies with Gamma-Glutamyl Transpeptidase. Bioorganic & Medicinal Chemistry Letters, 14, 3451- 3455. https://doi.org/10.1016/j.bmcl.2004.04.072
|
[75]
|
Han, L., Hiratake, J., Kamiyama, A., et al. (2007) Design, Synthesis, and Evaluation of Gamma-Phosphono Diester Analogues of Glutamate as Highly Potent Inhibitors and Active Site Probes of Gamma-Glutamyl Transpeptidase. Biochemistry, 46, 1432-1447. https://doi.org/10.1021/bi061890j
|
[76]
|
King, J.B., West, M.B., Cook, P.F., et al. (2009) A Novel, Species-Specific Class of Uncompetitive Inhibitors of Gamma-Glutamyl Transpeptidase. Journal of Biological Chemistry, 284, 9059-9065.
https://doi.org/10.1074/jbc.M809608200
|